A shot-in-the-arm
microchip could save
your life
August 29 2006
VeriMed implant lets
doctors scan patients
for health information
in a hurry
Monday, August 07, 2006
BY ANGELA STEWART
Star-Ledger Staff
Bergen County police
Sgt. William Koretsky
was barely conscious
when paramedics rushed
him to the emergency
room at Hackensack
University Medical
Center in May.
Suffering head trauma
after his cruiser hit a
telephone pole while on
a stolen-car chase, the
44-year-old diabetic was
in no shape to give
doctors his medical
history.
That job was left to a
tiny microchip buried
beneath the skin of his
right arm.
Doctors at Hackensack
simply waved a hand-held
scanner a couple of
inches above the elbow
on the back of
Koretsky's right arm,
and up popped a 16-digit
link to his electronic
medical records.
Hackensack is the first
New Jersey hospital to
adopt the VeriMed
patient identification
system, using a radio
frequency identification
microchip. And Koretsky
is believed to be the
first patient in the
United States to put the
chip to the test in an
actual emergency.
About the size of a
grain of rice, the chip
stores personal
identifiers, such as
name and address, as
well as medical
information and
emergency contacts. The
information is accessed
by computer after
entering a pass code and
user name.
"Until the accident, I
actually forgot it was
there," said Koretsky,
who has since returned
to work.
Koretsky had the chip
implanted last year at
the urging of Bergen
County Police Chief John
Schmidig, who also has
one.
Manufactured by VeriChip
Corp. of Delray Beach,
Fla., the chip was
approved by the Food and
Drug Administration in
October 2002. It belongs
to the same family of
technology used to scan
credit cards or road
toll transponders. A
"reader" communicates
with a "tag" that holds
digital information in a
microchip.
Chip implantation takes
about 10 minutes and is
much like getting an
injection. Koretsky said
he felt no pain because
doctors first numbed his
upper arm with an
anesthetic.
Richard Seelig,
VeriChip's vice
president for medical
applications, said the
company has been
introducing the
microchip to health care
facilities around the
country, especially in
the Northeast. It
currently has more than
100 medical facilities
committed to using the
technology and expects
another 100 to sign up
by the end of this year.
Worldwide, about 2,500
people have received
VeriChip implants.
"There is a universally
recognized need for
rapid access to medical
information," Seelig
said. When additional
patient information is
added to the VeriMed
system database, it is
automatically retrieved
when the chip is
scanned, so there is no
need to have a new chip
implanted, he added.
Horizon Blue Cross Blue
Shield of New Jersey
recently announced a
two-year collaboration
with Hackensack to add
some of its members to
the program. Horizon
will send 500 letters to
patients with chronic
illnesses, explaining
the benefits of getting
a chip implant.
"We are sitting on tons
and tons of patient
information and this is
a way for us to make
that information
available to those
taking care of the
patient," said Darryl
Donlin, Horizon's
manager of member
program development.
Horizon members who
participate will get an
implant at no cost under
the pilot program,
officials said. VeriChip
officials said the
device and implant
normally cost $200.
Seelig said the company
believes the microchip
is most suitable for
patients with cognitive
illnesses, such as
Alzheimer's disease;
people with implanted
medical devices, such as
pacemakers and cardiac
stents; and those
suffering from strokes
or chronic health
conditions, such as
congestive heart failure
or diabetes.
About 30 chronically ill
patients have been
implanted with the
device so far at
Hackensack. But the
trauma department is
scanning anyone who
comes in with a
condition that makes
communication difficult
or impossible, just in
case that patient has a
chip implant, said
Joseph Feldman,
department chairman.
Other health care
facilities in New
Jersey, such as the
Saint Barnabas Health
Care System, also are
looking into the
technology.
"We're evaluating it. We
want to make sure it's
the best (technology)
available," said John
Brennan, senior vice
president of clinical
and emergency services.
Angela Stewart writes
about health care. She
may be reached at
astewart@starledger.com
or (973) 392-4178.
|